JESSICA RICE: Open Payments
NPI 1992278394 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,580 in 31 payments from 6 companies in 2025. Trend: 2023 $1,372 · 2024 $2,924 · 2025 $8,580
Speaker / faculty: $8,063Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $8,398 |
| Teva Pharmaceuticals USA, Inc. | 4 | $97 |
| UCB, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: UBRELVY, QULIPTA, AJOVY, AUSTEDO XR, Briviact, IMBRUVICA, KISUNLA, Ocrevus Zunovo.
Industry payments across SC — which companies pay providers there.
